Invasive breast carcinoma - IARC

2746. Somerville JE, Clarke LA, Biggart JD
(1992). c-erbB-2 overexpression and histological
type of in situ and invasive breast
carcinoma. J Clin Pathol 45: 16-20.
2747. Sonnendecker HE, Cooper K, Kalian
KN (1994). Primary fallopian tube adenocarcinoma
in situ associated with adjuvant
tamoxifen therapy for breast carcinoma.
Gynecol Oncol 52: 402-407.
2748. Sonoda Y, Saigo PE, Federici MG,
Boyd J (2000). Carcinosarcoma of the
ovary in a patient with a germline BRCA2
mutation: evidence for monoclonal origin.
Gynecol Oncol 76: 226-229.
2749. Sood AK, Sorosky JI, Gelder MS,
Buller RE, Anderson B, Wilkinson EJ,
Benda JA, Morgan LS (1998). Primary ovarian
sarcoma: analysis of prognostic variables
and the role of surgical cytoreduction.
Cancer 82: 1731-1737.
2750 . Soomro S, Shousha S, Taylor P,
Shepard HM, Feldmann M (1991). c-erbB-2
expression in different histological types of
invasive breast carcinoma. J Clin Pathol
44: 211-214.
2751. Sorbe B, Risberg B, Thornthwaite J
(1994). Nuclear morphometry and DNA
flow cytometry as prognostic methods for
endometrial carcinoma. Int J Gynecol
Cancer 4: 94-100.
2752. Sordillo PP, Chapman R, Hajdu SI,
Magill GB, Golbey RB (1981). Lymphangiosarcoma.
Cancer 48: 1674-1679.
2753. Soreide JA, Anda O, Eriksen L, Holter
J, Kjellevold KH (1988). Pleomorphic adenoma
of the human breast with local
recurrence. Cancer 61: 997-1001.
2754. Sorensen FB, Paulsen SM (1987).
Glycogen-rich clear cell carcinoma of the
breast: a solid variant with mucus. A light
microscopic, immunohistochemical and
ultrastructural study of a case.
Histopathology 11: 857-869.
2755. Sorensen HT, Friis S, Olsen JH,
Thulstrup AM, Mellemkjaer L, Linet M,
Trichopoulos D, Vilstrup H, Olsen J (1998).
Risk of breast cancer in men with liver cir -
rhosis. Am J Gastroenterol 93: 231-233.
2756. Sorlie T, Perou CM, Tibshirani R, Aas
T, Geisler S, Johnsen H, Hastie T, Eisen
MB, van de Rijn M, Jeffrey SS, Thorsen T,
Quist H, Matese JC, Brown PO, Botstein D,
Eystein LP, Borresen-Dale AL (2001). Gene
expression patterns of breast carcinomas
distinguish tumor subclasses with clinical
implications. Proc Natl Acad Sci USA 98:
10869-10874.
2757. Sorlie T, Tibshirani R, Parker J, Hastie
T, Marron JS, Nobel A, Deng S, Johnsen H,
Pesich R, Geisler S, Demeter J, Perou CM,
Lonning PE, Brown PO, Borresen-Dale AL,
Botstein D (2003). Repeated observation of
breast tumor subtypes in independent
gene expression data sets. Proc Natl Acad
Sci USA 100: 8418-8423.
2758. Soslow RA, Rouse RV, Hendrickson
MR, Silva EG, Longacre TA (1996).
Transitional cell neoplasms of the ovary
and urinary bladder: a comparative
immunohistochemical analysis. Int J
Gynecol Pathol 15: 257-265.
2759. Soussi T (1996). The p53 tumour suppressor
gene: a model for molecular epidemiology
of human cancer. Mol Med
Today 2: 32-37.
2760. Soussi T, Beroud C (2001). Assessing
TP53 status in human tumours to evaluate
clinical outcome. Nat Rev Cancer 1: 233-
240.
2761. Soussi T, Dehouche K, Beroud C
(2000). p53 website and analysis of p53
gene mutations in human cancer: forging a
link between epidemiology and carcinogenesis.
Hum Mutat 15: 105-113.
2762. Spagnolo DV, Shilkin KB (1983).
Breast neoplasms containing bone and
cartilage. Virchows Arch A Pathol Anat
Histopathol 400: 287-295.
2763. Spatz A, Bouron D, Pautier P,
Castaigne D, Duvillard P (1998). Primary
yolk sac tumor of the endometrium: a case
report and review of the literature.
Gynecol Oncol 70: 285-288.
2764. Spiegel GW (1995). Endometrial carcinoma
in situ in postmenopausal women.
Am J Surg Pathol 19: 417-432.
2765. Spitz DJ, Reddy VB, Gattuso P (1999).
Fine-needle aspiration of pseudoangioma -
tous stromal hyperplasia of the breast.
Diagn Cytopathol 20: 323-324.
2766. Spitzer M (1999). Lower genital tract
intraepithelial neoplasia in HIV-infected
women: guidelines for evaluation and
management. Obstet Gynecol Surv 54: 131-
137.
2767. Sreenan JJ, Hart WR (1995).
Carcinosarcomas of the female genital
tract. A pathologic study of 29 metastatic
tumors: further evidence for the dominant
role of the epithelial component and the
conversion theory of histogenesis. Am J
Surg Pathol 19: 666-674.
2768. Srigley JR, Colgan TJ (1988).
Multifocal and diffuse adenomatoid tumor
involving uterus and fallopian tube.
Ultrastruct Pathol 12: 351-355.
2769. Srivatsa PJ, Keeney GL, Podratz KC
(1994). Disseminated cervical adenoma
malignum and bilateral ovarian sex cord
tumors with annular tubules associated
with Peutz-Jeghers syndrome. G y n e c o l
Oncol 53: 256-264.
2 7 7 0 . Ssali JC, Gakwaya A, Katongole-
Mbidde F (1995). Risk factors for breast
cancer in Ugandan women: a case-control
study. East Central Afr J Surg 1: 9-13.
2771. Staebler A, Heselmeyer-Haddad K,
Bell K, Riopel M, Perlman E, Ried T,
Kurman RJ (2002). Micropapillary serous
carcinoma of the ovary has distinct patterns
of chromosomal imbalances by comparative
genomic hybridization compared
with atypical proliferative serous tumors
and serous carcinomas. Hum Pathol 33: 47-
59.
2772. Staebler A, Lax SF, Ellenson LH
(2000). Altered expression of hMLH1 and
hMSH2 protein in endometrial carcinomas
with microsatellite instability. Hum Pathol
31: 354-358.
2773. Stalsberg H, Blom PE, Bostad LH,
Westgaard G (1983). An International
Survey of Distributions of Histologic Types
of Tumours of the Testis and Ovary
(Ovarian tumours and endometriosis in
Norway General Hospital material). UICC:
Geneva.
2774. Stambolic V, Suzuki A, de la Pompa
JL, Brothers GM, Mirtsos C, Sasaki T,
Ruland J, Penninger JM, Siderovski DP,
Mak TW (1998). Negative regulation of
PKB/Akt-dependent cell survival by the
tumor suppressor PTEN. Cell 95: 29-39.
2775. Stankovic T, Kidd AM, Sutcliffe A,
McGuire GM, Robinson P, Weber P,
Bedenham T, Bradwell AR, Easton DF,
Lennox GG, Haites N, Byrd PJ, Taylor AM
(1998). ATM mutations and phenotypes in
ataxia-telangiectasia families in the British
Isles: expression of mutant ATM and the
risk of leukemia, lymphoma, and breast
cancer. Am J Hum Genet 62: 334-345.
2775a. Stapleton JJ, Holser MH, Linder LE
(1981). Paramesonephric papillary serous
cystadenocarcinoma. A case report with
scanning electron microscopy. Acta Cytol
25: 310-316.
2776. Starink TM, van der Veen JP, Arwert
F, de Waal LP, de Lange GG, Gille JJ,
Eriksson AW (1986). The Cowden syndrome:
a clinical and genetic study in 21
patients. Clin Genet 29: 222-233.
2777. Steck PA, Pershouse MA, Jasser SA,
Yung WK, Lin H, Ligon AH, Langford LA,
Baumgard ML, Hattier T, Davis T, Frye C,
Hu R, Swedlund B, Teng DH, Tavtigian SV
(1997). Identification of a candidate tumour
suppressor gene, MMAC1, at chromosome
10q23.3 that is mutated in multiple
advanced cancers. Nat Genet 15: 356-362.
2778. Steeper TA, Piscioli F, Rosai J (1983).
Squamous cell carcinoma with sarcomalike
stroma of the female genital tract.
Clinicopathologic study of four cases.
Cancer 52: 890-898.
2779. Steeper TA, Rosai J (1983).
Aggressive angiomyxoma of the female
pelvis and perineum. Report of nine cases
of a distinctive type of gynecologic soft-tissue
neoplasm. Am J Surg Pathol7: 463-475.
2780. Steeper TA, Wick MR (1986). Minimal
deviation adenocarcinoma of the uterine
cervix ("adenoma malignum"). An immunohistochemical
comparison with microglandular
endocervical hyperplasia and conventional
endocervical adenocarcinoma.
Cancer 58: 1131-1138.
2781. Stefani M, Speranza N (1970). [A case
of cylindroma of the vagina]. Riv Anat
Patol Oncol 36: 77-105.
2782. Stehman FB, Bundy BN, Disaia PJ,
Keys HM, Larson JE, Fowler WC (1991).
Carcinoma of the cervix treated with radiation
therapy. I. A multi-variate analysis of
prognostic variables in the Gynecologic
Oncology Group. Cancer 67: 2776-2785.
2783. Stehman FB, Bundy BN, Dvoretsky
PM, Creasman WT (1992). Early stage I
carcinoma of the vulva treated with ipsilateral
superficial inguinal lymphadenectomy
and modified radical hemivulvectomy: a
prospective study of the Gynecologic
Oncology Group. Obstet Gynecol 79: 490-
497.
2784. Steingaszner LC, Enzinger FM, Taylor
HB (1965). Hemangiosarcoma of the
breast. Cancer 18: 352-361.
2785. Stenkvist B, Bengtsson E, Dahlqvist
B, Eklund G, Eriksson O, Jarkrans T, Nordin
B (1982). Predicting breast cancer recurrence.
Cancer 50: 2884-2893.
2786. Stenwig JT, Hazekamp JT, Beecham
JB (1979). Granulosa cell tumors of the
ovary. A clinicopathological study of 118
cases with long-term follow-up. Gynecol
Oncol 7: 136-152.
2787. Stephenson TJ, Mills PM (1986).
Adenomatoid tumours: an immunohistochemical
and ultrastructural appraisal of
their histogenesis. J Pathol 148: 327-335.
2788. Sternberg WH, Barclay DL (1966).
Luteoma of pregnancy. Am J Obstet
Gynecol 95: 165-184.
2789. Sternberg WH, Roth LM (1973).
Ovarian stromal tumors containing Leydig
cells. I. Stromal-Leydig cell tumor and nonneoplastic
transformation of ovarian stroma
to Leydig cells. Cancer 32: 940-951.
2790. Stettner AR, Hartenbach EM, Schink
JC, Huddart R, Becker J, Pauli R, Long R,
Laxova R (1999). Familial ovarian germ cell
cancer: report and review. Am J Med
Genet 84: 43-46.
2791. Stevens RG (1987). Electric power
use and breast cancer: a hypothesis. Am J
Epidemiol 125: 556-561.
2792. Stewart CJ, Nandini CL, Richmond JA
(2000). Value of A103 (melan-A) immunostaining
in the differential diagnosis of ovarian
sex cord stromal tumours.J Clin Pathol
53: 206-211.
2793. Stewart FW, Treves N (1949).
Lymphangiosarcoma in postmastectomy
lymphedema. A report of six cases of elephantiasis
chirurgica. Cancer 1: 64-81.
2794. Stock RJ, Zaino R, Bundy BN, Askin
FB, Woodward J, Fetter B, Paulson JA,
Disaia PJ, Stehman FB (1994). Evaluation
and comparison of histopathologic grading
systems of epithelial carcinoma of the
uterine cervix: Gynecologic Oncology
Group studies. Int J Gynecol Pathol 13: 99-
108.
2795. Stocks LH, Patterson FM (1976).
Inflammatory carcinoma of the breast.
Surg Gynecol Obstet 143: 885-889.
2796. Stomper PC, Connolly JL (1992).
Ductal carcinoma in situ of the breast: correlation
between mammographic calcification
and tumor subtype. AJR Am J
Roentgenol 159: 483-485.
2797. Stone GC, Bell DA, Fuller A, Dickersin
GR, Scully RE (1986). Malignant schwannoma
of the ovary. Report of a case. Cancer
58: 1575-1582.
2798. Storm HH, Jensen OM (1986). Risk of
contralateral breast cancer in Denmark
1943-80. Br J Cancer 54: 483-492.
2799. Storm HH, Olsen J (1999). Risk of
breast cancer in offspring of male breastcancer
patients. Lancet 353: 209.
2800. Stratton JF, Gayther SA, Russell P,
Dearden J, Gore M, Blake P, Easton D,
Ponder BA (1997). Contribution of BRCA1
mutations to ovarian cancer. N Engl J Med
336: 1125-1130.
2801. Stratton JF, Pharoah P, Smith SK,
Easton D, Ponder BA (1998). A systematic
review and meta-analysis of family history
and risk of ovarian cancer. Br J Obstet
Gynaecol 105: 493-499.
2802. Stratton JF, Thompson D, Bobrow L,
Dalal N, Gore M, Bishop DT, Scott I, Evans
G, Daly P, Easton DF, Ponder BA (1999).
The genetic epidemiology of early-onset
epithelial ovarian cancer: a populationbased
study. Am J Hum Genet 65: 1725-
1732.
2803. Straughn JM Jr., Richter HE, Conner
MG, Meleth S, Barnes MN (2001).
Predictors of outcome in small cell carcinoma
of the cervix--a case series.
Gynecol Oncol 83: 216-220.
2804. Sturgeon SR, Brinton LA, Devesa SS,
Kurman RJ (1992). In situ and invasive vulvar
cancer incidence trends (1973 to 1987).
Am J Obstet Gynecol 166: 1482-1485.
2805. Sturgeon SR, Sherman ME, Kurman
RJ, Berman ML, Mortel R, Twiggs LB,
Barrett RJ, Wilbanks GD, Brinton LA (1998).
Analysis of histopathological features of
endometrioid uterine carcinomas and epidemiologic
risk factors. Cancer Epidemiol
Biomarkers Prev 7: 231-235.
416 References